Mesoblast (MEOBF) Current Deferred Revenue (2015 - 2020)

Mesoblast has disclosed Current Deferred Revenue across 4 years of filings, most recently posting $10.0 million for Q2 2020.

• In Q2 2020, Current Deferred Revenue changed 0.0% year-over-year to $10.0 million; the TTM figure through Jun 2020 stood at $10.0 million (changed 0.0% YoY), while the FY2020 annual figure was $10.0 million, changed 0.0% from the prior year.
• Current Deferred Revenue came in at $10.0 million for Q2 2020 at Mesoblast, roughly flat from $10.0 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $15.0 million in Q1 2016 to a low of $10.0 million in Q1 2019.
• Average Current Deferred Revenue over 3 years is $10.7 million, with a median of $10.0 million recorded in 2019.
• The largest YoY upside for Current Deferred Revenue was 0.0% in 2020 against a maximum downside of 0.0% in 2020.
• Over 3 years, Current Deferred Revenue stood at $15.0 million in 2016, then plunged by 33.35% to $10.0 million in 2019, then changed by 0.0% to $10.0 million in 2020.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $10.0 million in Q2 2020, $10.0 million in Q1 2020, and $10.0 million in Q4 2019.